Qelbree, a medication for treating certain types of seizures associated with epilepsy, has varying costs depending on insurance coverage. For individuals with commercial insurance, the out-of-pocket cost can be as low as $0 for the first prescription and $25 per month for subsequent refills through a savings program offered by the manufacturer [1].
What is the list price of Qelbree?
The list price for Qelbree can be significantly higher without insurance. For example, a 30-day supply of Qelbree (400 mg) has a list price of $1,700 [1].
How does insurance affect Qelbree costs?
Insurance plans differ in their coverage and copay requirements for Qelbree. Patients often experience reduced costs compared to the list price when their insurance covers the medication. The manufacturer's savings program is designed to further lower out-of-pocket expenses for eligible patients with commercial insurance [1].
Are there patient assistance programs for Qelbree?
Yes, there are patient assistance programs available. The Qelbree Savings Card program offers eligible commercially insured patients the opportunity to pay as little as $0 for their first prescription and $25 per month for refills. This program has monthly and annual maximum benefits [1]. For uninsured patients or those with government-funded insurance, other assistance options might be available through the manufacturer or third-party foundations, though specific details would need to be confirmed directly.
How long does Qelbree take to work?
The time it takes for Qelbree to become effective can vary among individuals. Clinical studies indicate that Qelbree is typically taken for up to 12 weeks to achieve its full therapeutic effect [2].
What are the common side effects of Qelbree?
Common side effects reported with Qelbree include somnolence, decreased appetite, fatigue, nausea, vomiting, and difficulty sleeping [2]. Some patients may also experience behavioral changes.
What are the potential risks of taking Qelbree?
Qelbree carries a boxed warning regarding suicidal behavior and ideation. Patients, their caregivers, and families should be alerted to monitor for any new or worsening depression, unusual changes in behavior, or suicidal thoughts and behaviors. Other serious risks may include hypersensitivity reactions [2].
When does the patent for Qelbree expire?
Patent information for medications like Qelbree is tracked and updated. Specific patent expiry dates can be found on resources that monitor drug patents [3].
How does Qelbree compare to other epilepsy medications?
Qelbree is a selective norepinephrine reuptake inhibitor (SNRI), distinguishing its mechanism of action from many other antiepileptic drugs that primarily target GABA or glutamate pathways. Its efficacy and side effect profile may differ from other available treatments [2].
Sources:
1. https://www.qelbree.com/savings-and-support/
2. https://www.qelbree.com/
3. https://drugpatentwatch.com/